Spira, Avi

Pioglitazone as a candidate chemoprevention agent for lung cancer: A pilot window trial in early stage NSCLC.

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 1581-1581

10.1200/jco.2014.32.15_suppl.1581